Launched recently under the expert leadership of Editor-in-Chief Professor Shengdi Chen from Ruijin Hospital at Shanghai Jiaotong University in China, Translational Neurodegeneration creates a new interface between the fields of basic, translational, and clinical research into neurodegenerative diseases.
Supported by a well respected international Editorial Board, who cover Parkinson’s disease and movement disorders, Alzheimer’s disease and other dementias, motor neuron disease plus other neurodegenerative diseases, the journal has been created to help you share your knowledge and experience of the latest research on the epidemiology, etiology, pathogenesis, diagnosis, management and prevention of neurodegenerative diseases.
The initial articles reflect the standard and reach of the journal, such as research by Glenda Halliday et al. to determine whether macroautophagy is increased by the A53T alpha-synuclein gene mutation in Parkinson’s Disease patients and cell models. A review by Shu-Leong Ho et al. gives a brief insight into Mitochondrial neuronal uncoupling proteins. Peter LeWitt discusses the wide role of norepinephrine, and Jon Stoessl introduces the latest progress in his review “Neuroimaging in the early diagnosis of neurodegenerative diseases”.
Excited by the launch, Professor Shengdi Chen and Associate Editor, Jialin Zheng state in their introductory editorial: "By offering a high-visibility forum for new insights and discussions of translational research in neurodegenerative diseases, Translational Neurodegeneration will promote the rapid conversion of basic research to clinical applications benefiting patients better and faster.”